Tingting Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tingting Ma has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Bin Li
Acupuncture and Moxibustion Department, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, No.23 Meishuguanhou Street, Dongcheng District, Beijing, 100010, China
2 shared publications - Gan-Lin Zhang
Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
2 shared publications Haiming Li
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China
2 shared publications- Lin-Peng Wang
Acupuncture and Moxibustion Department, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing, China
2 shared publications Xiaohui Yin
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China
2 shared publications- Xiaomin Wang
Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
2 shared publications
Latest Publications
- Open Access
- 17 October 2023
- Published by Springer Nature in Research Square
Acupuncture for insomnia in patients with breast cancer: a single-center, single-blind, randomised, controlled trial protocol
Background Patients with breast cancer have a high incidence of insomnia, which is often accompanied by anxiety, depression, and fatigue. Acupuncture is considered useful for insomnia and emotional disorders and is becoming increasingly acceptable for patients with cancer. However, few studies have been conducted on acupuncture for patients with breast cancer who are suffering from insomnia. This study aims to describe a protocol for an 8-week acupuncture intervention to explore the efficacy and safety of acupuncture therapy using the “regulating spirit and soothing liver” method for treating insomnia patients with breast cancer. Methods This study is a single-center, single-blind, randomised, controlled trial. We aim to recruit 70 females, aged 18-60 years, who will be randomly allocated to the intervention (acupuncture) or control (sham acupuncture) groups. The intervention will include an 8-week acupuncture therapy followed by a 3-month follow-up period. The primary outcome is the Pittsburgh Sleep Scale(PSQI) measured every two weeks. Secondary outcomes are the Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ9), and Functional Assessment of Cancer Therapy-Breast Cancer (FACT-B) to assess emotional health and quality of life. We will also record the drug name and quantity given to treat severe insomnia. We also will measure serum 5-hydroxytryptamine(5-HT) concentrations at baseline and again at 4 and 8 weeks. Adverse events will be recorded in detail throughout the trial. Intention-to -treat analyses will be conducted, and the data will be assessed using a global statistical test. Ethical approval for this trial was granted by the Institutional Ethics Committee of the Beijing Hospital of Traditional Chinese Medicine, Capital Medical University(2022BL02-059-02). Written informed consent was obtained from enrolled patients and will last throughout the trial. The trial results will be disseminated through peer-reviewed publications and conferences. Discussion Patients with breast cancer are more likely to experience insomnia, and it may influence the curative effect of their treatments. Undoubtedly, more attention is needed regarding insomnia in these patients; however, there is no established principle or guideline for patients with breast cancer who take multiple different medicines. Therefore, acupuncture may be useful as a less harmful intervention. Trial registration number ISRCTN12913513, 7 March,2023
- 17 October 2023
- Published by Springer Nature in Research Square
Open AccessAcupuncture for insomnia in patients with breast cancer: a single-center, single-blind, randomised, controlled trial protocol
Background Patients with breast cancer have a high incidence of insomnia, which is often accompanied by anxiety, depression, and fatigue. Acupuncture is considered useful for insomnia and emotional disorders and is becoming increasingly acceptable for patients with cancer. However, few studies have been conducted on acupuncture for patients with breast cancer who are suffering from insomnia. This study aims to describe a protocol for an 8-week acupuncture intervention to explore the efficacy and safety of acupuncture therapy using the “regulating spirit and soothing liver” method for treating insomnia patients with breast cancer. Methods This study is a single-center, single-blind, randomised, controlled trial. We aim to recruit 70 females, aged 18-60 years, who will be randomly allocated to the intervention (acupuncture) or control (sham acupuncture) groups. The intervention will include an 8-week acupuncture therapy followed by a 3-month follow-up period. The primary outcome is the Pittsburgh Sleep Scale(PSQI) measured every two weeks. Secondary outcomes are the Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ9), and Functional Assessment of Cancer Therapy-Breast Cancer (FACT-B) to assess emotional health and quality of life. We will also record the drug name and quantity given to treat severe insomnia. We also will measure serum 5-hydroxytryptamine(5-HT) concentrations at baseline and again at 4 and 8 weeks. Adverse events will be recorded in detail throughout the trial. Intention-to -treat analyses will be conducted, and the data will be assessed using a global statistical test. Ethical approval for this trial was granted by the Institutional Ethics Committee of the Beijing Hospital of Traditional Chinese Medicine, Capital Medical University(2022BL02-059-02). Written informed consent was obtained from enrolled patients and will last throughout the trial. The trial results will be disseminated through peer-reviewed publications and conferences. Discussion Patients with breast cancer are more likely to experience insomnia, and it may influence the curative effect of their treatments. Undoubtedly, more attention is needed regarding insomnia in these patients; however, there is no established principle or guideline for patients with breast cancer who take multiple different medicines. Therefore, acupuncture may be useful as a less harmful intervention. Trial registration number ISRCTN12913513, 7 March,2023
- Open Access
- 10 July 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-6
A clinical study to assess the influence of acupuncture at “Wang’s Jiaji” acupoints on limb spasticity in patients in convalescent stage of ischemic stroke: study protocol for a randomized controlled trial
Stroke is characterized by high morbidity, high mortality, and high disability. Spasticity, one of the most common complications after stroke, may reduce the potential success of rehabilitation and has a detrimental effect on stroke patients’ daily function and quality of life. Moreover, the long-term management of spasticity is a financial burden to patients and increases societal costs. The current treatments, mainly including physical therapy, oral drugs, drug injection therapy, and surgical interventions, have been used to reduce spasticity. However, every conventional approach has its limitations. Acupuncture at the “Wang’s Jiaji” acupoints, based on the experience of the famous old doctor of traditional Chinese medicine (TCM) Le Ting Wang in treating post-stroke limb spasm, has been widely practiced in our department. This intervention has effectively avoided the controversy around acupuncture at local acupoints on the limbs, and is easy to apply without side effects. Our previous studies had found that acupuncture at the “Wang’s Jiaji-points” can reduce the occurrence and severity of spasticity occurring after stroke in the early stage (the first 21 days). In this study, we chose patients in the convalescent stage, 1–6 months after stroke, so as to study the efficacy and the specific intervention time of “Wang’s jiaji” in the convalescent stage after stroke. This is a randomized, controlled, and single-blind study. Patients in the convalescent stage within 1–6 months of ischemic stroke will be selected as subjects. A total of 100 subjects will be randomly assigned to two groups. The acupuncture group will be given acupuncture treatment five times a week; the medicine group will be given 10mg baclofen three times a day. These two groups will continue to receive current usual care for the prevention and treatment of cerebrovascular diseases, but drugs that affect muscle tone will not be allowed. The treatment will last for 2 weeks. The primary outcome measurement is the simplified Fugl-Meyer Assessment. The secondary outcome measurements are the Modified Ashworth Scale, Modified Barthel Scale, and the H-reflex, F response, and H/M ratios of electromyography. All outcome measurements are assessed at baseline, 2 weeks, 4 weeks, and 12 weeks after first treatment except the electromyography, which is assessed at baseline and 2 weeks after first acupuncture. This trial aims to evaluate the effects and the specific intervention time of “Wang’s Jiaji” acupoints on spasticity after stroke. ISRCTN registry, ISRCTN31511176 . Registered on 29 August 2017. Version number of protocol 2016-2-1161 Version date of protocol: 2016-1
- 10 July 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-6
Open AccessA clinical study to assess the influence of acupuncture at “Wang’s Jiaji” acupoints on limb spasticity in patients in convalescent stage of ischemic stroke: study protocol for a randomized controlled trial
Stroke is characterized by high morbidity, high mortality, and high disability. Spasticity, one of the most common complications after stroke, may reduce the potential success of rehabilitation and has a detrimental effect on stroke patients’ daily function and quality of life. Moreover, the long-term management of spasticity is a financial burden to patients and increases societal costs. The current treatments, mainly including physical therapy, oral drugs, drug injection therapy, and surgical interventions, have been used to reduce spasticity. However, every conventional approach has its limitations. Acupuncture at the “Wang’s Jiaji” acupoints, based on the experience of the famous old doctor of traditional Chinese medicine (TCM) Le Ting Wang in treating post-stroke limb spasm, has been widely practiced in our department. This intervention has effectively avoided the controversy around acupuncture at local acupoints on the limbs, and is easy to apply without side effects. Our previous studies had found that acupuncture at the “Wang’s Jiaji-points” can reduce the occurrence and severity of spasticity occurring after stroke in the early stage (the first 21 days). In this study, we chose patients in the convalescent stage, 1–6 months after stroke, so as to study the efficacy and the specific intervention time of “Wang’s jiaji” in the convalescent stage after stroke. This is a randomized, controlled, and single-blind study. Patients in the convalescent stage within 1–6 months of ischemic stroke will be selected as subjects. A total of 100 subjects will be randomly assigned to two groups. The acupuncture group will be given acupuncture treatment five times a week; the medicine group will be given 10mg baclofen three times a day. These two groups will continue to receive current usual care for the prevention and treatment of cerebrovascular diseases, but drugs that affect muscle tone will not be allowed. The treatment will last for 2 weeks. The primary outcome measurement is the simplified Fugl-Meyer Assessment. The secondary outcome measurements are the Modified Ashworth Scale, Modified Barthel Scale, and the H-reflex, F response, and H/M ratios of electromyography. All outcome measurements are assessed at baseline, 2 weeks, 4 weeks, and 12 weeks after first treatment except the electromyography, which is assessed at baseline and 2 weeks after first acupuncture. This trial aims to evaluate the effects and the specific intervention time of “Wang’s Jiaji” acupoints on spasticity after stroke. ISRCTN registry, ISRCTN31511176 . Registered on 29 August 2017. Version number of protocol 2016-2-1161 Version date of protocol: 2016-1
- Open Access
- 24 June 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-10
Effect of acupuncture on cerebrovascular reserve in patients with acute cerebral infarction: protocol for a randomized controlled pilot study
The incidence of cerebral infarction has been growing year by year in China and around the world. According to clinical observation, acupuncture utilizing the “waking up the spirit” needling method is widely used in patients with cerebral infarction, though the underlying mechanisms remain unclear. Additionally, a number of studies have begun to focus on the relationship between cerebrovascular reserve (CVR) and cerebral infarction. The present study aims to investigate whether CVR is one of potential mechanisms underpinning this effect of acupuncture on patients with cerebral infarction. This is a single-centre, prospective, single-blinded, randomized controlled pilot study. Sixty eligible patients will be randomized into an intervention group (waking up the spirit acupuncture) and a control group (hand and foot 12-meridian acupuncture) in a 1:1 ratio. All treatments will be conducted once a day on weekdays followed by a 2-day rest period on the weekend, over a total treatment course of 2 weeks. The primary outcome measures are cerebrovascular reserve (CVR) capacity and Breath-holding Index (BHI) which will be evaluated at baseline and 2 weeks after the first acupuncture treatment, and the secondary outcome measures are National Institutes of Health Stroke Scale (NIHSS) and Barthel Index scores which will be used to further evaluate the efficacy of the intervention. Cerebrovascular reserve is an independent risk factor for the occurrence, progression, and recurrence of cerebral infarction that requires attention. This trial aims to investigate whether acupuncture utilizing the waking up the spirit needling method can improve CVR capacity in patients with acute cerebral infarction, thus reducing NIHSS scores and preventing further progression of the disease. Furthermore, data and evidence gained from this study will be utilized in the development of future research projects regarding the effects of acupuncture in patients with acute cerebral infarction. ISRCTN, ID: ISRCTN99117074 . Registered on 20 April 2016.
- 24 June 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-10
Open AccessEffect of acupuncture on cerebrovascular reserve in patients with acute cerebral infarction: protocol for a randomized controlled pilot study
The incidence of cerebral infarction has been growing year by year in China and around the world. According to clinical observation, acupuncture utilizing the “waking up the spirit” needling method is widely used in patients with cerebral infarction, though the underlying mechanisms remain unclear. Additionally, a number of studies have begun to focus on the relationship between cerebrovascular reserve (CVR) and cerebral infarction. The present study aims to investigate whether CVR is one of potential mechanisms underpinning this effect of acupuncture on patients with cerebral infarction. This is a single-centre, prospective, single-blinded, randomized controlled pilot study. Sixty eligible patients will be randomized into an intervention group (waking up the spirit acupuncture) and a control group (hand and foot 12-meridian acupuncture) in a 1:1 ratio. All treatments will be conducted once a day on weekdays followed by a 2-day rest period on the weekend, over a total treatment course of 2 weeks. The primary outcome measures are cerebrovascular reserve (CVR) capacity and Breath-holding Index (BHI) which will be evaluated at baseline and 2 weeks after the first acupuncture treatment, and the secondary outcome measures are National Institutes of Health Stroke Scale (NIHSS) and Barthel Index scores which will be used to further evaluate the efficacy of the intervention. Cerebrovascular reserve is an independent risk factor for the occurrence, progression, and recurrence of cerebral infarction that requires attention. This trial aims to investigate whether acupuncture utilizing the waking up the spirit needling method can improve CVR capacity in patients with acute cerebral infarction, thus reducing NIHSS scores and preventing further progression of the disease. Furthermore, data and evidence gained from this study will be utilized in the development of future research projects regarding the effects of acupuncture in patients with acute cerebral infarction. ISRCTN, ID: ISRCTN99117074 . Registered on 20 April 2016.